Abstract:Microscopic polyangiitis (MPA) is a form of necrotizing vasculitis affecting the small vessels. Our study is the first study with the objective of describing the difference in clinical presentation of MPA and response to treatment at 6 months based on the age of disease onset. All patients seen at a tertiary vasculitis clinic between 2015 and 2023 with a diagnosis of MPA were included. Patients were divided into an elderly group (age > = 65 years) and a younger group (age < 65). Comparative analysis was conducted to characterize differences amongst the elderly and younger patients, including differences in organ involvement and clinical presentation, Birmingham Vasculitis Activity Score (BVAS) scores, Vasculitis Damage Index( VDI) scores, and response to treatment at 6 months. Thirty-one patients were included in our study. Younger MPA patients (n = 18) with mean age at diagnosis of 53.17 years were compared with older MPA patients(n = 13) with mean age at diagnosis of 76.08 years. The younger patients had statistically significant higher BVAS scores (p = 0.009), along with higher incidence of renal (p = 0.028), pulmonary (p = 0.0069), and cutaneous (p = 0.026) manifestations at disease onset. Furthermore, amongst the younger population, there was noted statistically significant clinical improvement at 6 months following treatment induction, particularly in the domains of general symptoms (p = 0.011), MSK (p = 0.019), cutaneous (p = 0.011), and pulmonary symptoms (p = 0.04). In contrast, the elderly population presented with a predominant of non-specific constitutional symptoms, with statistically significant improvement in the domain of non-specific general symptoms at 6 months (p = 0.00008). All MPA patients responded well to treatment, with statistically significant improvement amongst younger patients (p = 0.0032), but no statistically significant improvement amongst elderly patients (p = 0.67). Our study findings concluded that MPA's clinical presentation differed by age group. Younger patients had more aggressive vasculitis disease presentation with better response to treatments, whereas, elderly patients had less severe disease presentation with predominant of general symptoms at disease onset. Key Points • MPA clinical presentation differed by age at disease onset. Younger patients presented with more aggressive and classic vasculitis-like presentations, with multi-system organ involvement and statistically significant higher incidence of renal, pulmonary, and cutaneous manifestations. In contrast, elderly patients had a predominant of constitutional and non-specific symptoms with often delayed diagnosis. • All MPA patients responded well to treatment. Amongst the younger population, there was statistically significant improvement in BVAS scores after treatment induction at 6 months; however, there was no statistically significant improvement of BVAS scores in the elderly population. • Future studies are required to further understand the difference in the clinical presentation of MPA based on the age at disease onset, and the implication on disease diagnosis and management.

Clinical Phenotypes and Prognoses of Microscopic Polyangiitis Based on Kidney Biopsies

The Clinical and Pathological Features of Children With Microscopic Polyangiitis

Analysis of clinical, pathological features and prognosis of microscopic polyangiitis

Manifestation and long-term prognosis in microscopic polyangiitis patients with pulmonary involvement

Clinical and pathological characterization of patients with microscopic polyangiitis with medium artery involvement.

Predicting mortality in microscopic polyangiitis with renal involvement: a survival analysis based on 64 patients.

Pathological Classification and Prognosis of Renal Damage Caused by Antineutrophil Cytoplasmic Antibody Associated Vasculitis

[Clinicopathologic Analysis of 34 Patients with Microscopic Polyangitis].

Clinical Characteristics and Prognosis in 269 Patients with Antineutrophil Cytoplasimc Antibody Associated Vasculitis.

Clinical Characteristics in Ten Microscopic Polyangiitis Patients

[Clinical Characteristics and Treatment Outcomes of Microscopic Polyangiitis Combined with Autoimmune Hemolytic Anemia].

Prognosis of Microscopic Polyangiitis with Renal Involvement: Report of 60 Chinese Patients.

Myeloperoxidase-ANCA-positive Granulomatosis with Polyangiitis is a Distinct Subset of ANCA-associated Vasculitis: A Retrospective Analysis of 455 Patients from a Single Center in China

Significance of clinical‐immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis

Elderly versus younger patients with microscopic polyangiitis vasculitis (MPA): a single-center retrospective study

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients

Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease

Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities

Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis

Clinical and pathological analysis of 16 cases of microscopic polyangitis

Long-term Outcome of Mycophenolate Mofetil Treatment for Patients with Microscopic Polyangiitis: an Observational Study in Chinese Patients